CurveBeam AI (ASX:CVB) Research & Development: A$0.43 Mil (TTM As of Dec. 2025)


What is CurveBeam AI Research & Development?

CurveBeam AI ASX:CVB -6.67% Research & Development is A$0.43 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. CurveBeam AI's Research & Development for the six months ended in Dec. 2025 was A$0.21 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.43 Mil.

CurveBeam AI  (ASX:CVB) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CurveBeam AI Research & Development Related Terms

CurveBeam AI Research & Development Historical Data

* Premium members only.

The historical data trend for CurveBeam AI's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CurveBeam AI Research & Development Chart

CurveBeam AI Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Research & Development
0.00 0.00 0.59 0.77 0.45

CurveBeam AI Semi-Annual Data
Jun21 Dec21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only 0.48 0.29 0.24 0.22 0.21

CurveBeam AI Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.43 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of A$0.43 Mil mean?
CurveBeam AI (ASX:CVB) has a Research & Development of A$0.43 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on CurveBeam AI and its competitors.
Is CurveBeam AI's Research & Development too high?
CurveBeam AI's current Research & Development is A$0.43 Mil.
How does CurveBeam AI's Research & Development compare to ABT and SYK?
CurveBeam AI's Research & Development of A$0.43 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on CurveBeam AI and its competitors. CurveBeam AI's current Research & Development is A$0.43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CurveBeam AI stock overvalued right now?
CurveBeam AI (ASX:CVB) has a current Research & Development of A$0.43 Mil. The current Research & Development is A$0.43 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For CurveBeam AI (ASX:CVB), the current Research & Development is A$0.43 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CurveBeam AI Business Description

Address 10 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the company's CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.